| Exec date | Filing date | Company | Role | Signal | Confidence | Shares | % of shares | Under plan? | Amount (USD) |
|---|---|---|---|---|---|---|---|---|---|
| Feb 2, 2024 | Feb 2, 2024 | Merck & Co., Inc. | EVP, General Counsel | Sell | 16.3 | -49,499 | -63.01% | ✗ | $6.3M |
| May 4, 2023 | May 5, 2023 | Merck & Co., Inc. | EVP, General Counsel | Sell | 17.5 | -19,141 | -35.27% | ✗ | $2.3M |
| Feb 3, 2023 | Feb 6, 2023 | Merck & Co., Inc. | EVP, General Counsel | Sell | 16.3 | -75,436 | -58.32% | ✗ | $7.8M |
| Oct 28, 2022 | Nov 1, 2022 | Merck & Co., Inc. | EVP, General Counsel | Sell | 15.0 | -165,255 | -53.86% | ✗ | $16.4M |
| May 4, 2021 | May 6, 2021 | Merck & Co., Inc. | EVP, General Counsel | Sell | 22.5 | -2,843 | -7.69% | ✗ | $216K |
| May 4, 2020 | May 6, 2020 | Merck & Co., Inc. | EVP, General Counsel | Sell | 22.5 | -2,843 | -29.96% | ✗ | $220.8K |
| May 4, 2019 | May 7, 2019 | Merck & Co., Inc. | EVP, General Counsel | Sell | 22.5 | -2,154 | -37.32% | ✗ | $172.3K |